BDTX
Price
$2.32
Change
-$0.20 (-7.94%)
Updated
Feb 4, 02:25 PM (EDT)
Capitalization
143.58M
42 days until earnings call
Intraday BUY SELL Signals
BEAM
Price
$26.46
Change
-$1.42 (-5.09%)
Updated
Feb 4, 02:25 PM (EDT)
Capitalization
2.83B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs BEAM

Header iconBDTX vs BEAM Comparison
Open Charts BDTX vs BEAMBanner chart's image
Black Diamond Therapeutics
Price$2.32
Change-$0.20 (-7.94%)
Volume$600
Capitalization143.58M
Beam Therapeutics
Price$26.46
Change-$1.42 (-5.09%)
Volume$500
Capitalization2.83B
BDTX vs BEAM Comparison Chart in %
View a ticker or compare two or three
VS
BDTX vs. BEAM commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and BEAM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BDTX: $2.52 vs. BEAM: $27.89)
Brand notoriety: BDTX and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 99% vs. BEAM: 66%
Market capitalization -- BDTX: $143.58M vs. BEAM: $2.83B
BDTX [@Biotechnology] is valued at $143.58M. BEAM’s [@Biotechnology] market capitalization is $2.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BDTX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 3 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 3 bearish.
  • BEAM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BDTX is a better buy in the short-term than BEAM.

Price Growth

BDTX (@Biotechnology) experienced а -2.70% price change this week, while BEAM (@Biotechnology) price change was -9.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

BDTX is expected to report earnings on Mar 18, 2026.

BEAM is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.83B) has a higher market cap than BDTX($144M). BDTX YTD gains are higher at: 3.704 vs. BEAM (0.613). BDTX has higher annual earnings (EBITDA): 12.2M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. BDTX (136M). BDTX has less debt than BEAM: BDTX (19.7M) vs BEAM (151M). BDTX has higher revenues than BEAM: BDTX (70M) vs BEAM (55.7M).
BDTXBEAMBDTX / BEAM
Capitalization144M2.83B5%
EBITDA12.2M-434.55M-3%
Gain YTD3.7040.613604%
P/E Ratio6.81N/A-
Revenue70M55.7M126%
Total Cash136M1.08B13%
Total Debt19.7M151M13%
FUNDAMENTALS RATINGS
BDTX vs BEAM: Fundamental Ratings
BDTX
BEAM
OUTLOOK RATING
1..100
6974
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4697
PRICE GROWTH RATING
1..100
6344
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (35) in the null industry is in the same range as BDTX (49). This means that BEAM’s stock grew similarly to BDTX’s over the last 12 months.

BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as BDTX (100). This means that BEAM’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's SMR Rating (46) in the null industry is somewhat better than the same rating for BEAM (97). This means that BDTX’s stock grew somewhat faster than BEAM’s over the last 12 months.

BEAM's Price Growth Rating (44) in the null industry is in the same range as BDTX (63). This means that BEAM’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's P/E Growth Rating (99) in the null industry is in the same range as BEAM (100). This means that BDTX’s stock grew similarly to BEAM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDTXBEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signal:
Gain/Loss:
BEAM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRDC0.880.01
+1.62%
Laredo Oil, Inc
AIBGY23.050.09
+0.39%
AIB Group PLC
JXFGF0.29N/A
N/A
JINXIN FERTILITY GROUP LTD.
ROYUF73.11N/A
N/A
Royal Unibrew A S
AGXTF0.04N/A
N/A
ARGENTEX GROUP PLC

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with NUVL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-0.79%
NUVL - BDTX
46%
Loosely correlated
+2.12%
BEAM - BDTX
46%
Loosely correlated
-0.11%
IMCR - BDTX
45%
Loosely correlated
-2.94%
CRBU - BDTX
45%
Loosely correlated
+6.85%
DNLI - BDTX
44%
Loosely correlated
-4.22%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.11%
CRSP - BEAM
66%
Closely correlated
+1.34%
RXRX - BEAM
62%
Loosely correlated
-1.91%
NTLA - BEAM
62%
Loosely correlated
-0.08%
PRME - BEAM
61%
Loosely correlated
+0.26%
VIR - BEAM
58%
Loosely correlated
-0.39%
More